Wealth Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.1M Sell
7,717
-158
-2% -$160K 0.7% 27
2025
Q4
$8.46M Sell
7,875
-85
-1% -$81.3K 0.83% 23
2025
Q3
$6.07M Sell
7,960
-422
-5% -$314K 0.62% 24
2025
Q2
$6.53M Buy
8,382
+824
+11% +$640K 0.73% 24
2025
Q1
$6.24M Buy
7,558
+227
+3% +$189K 0.76% 23
2024
Q4
$5.66M Buy
7,331
+457
+7% +$378K 0.68% 22
2024
Q3
$6.09M Buy
6,874
+138
+2% +$124K 0.73% 20
2024
Q2
$6.1M Sell
6,736
-573
-8% -$458K 0.79% 20
2024
Q1
$5.69M Buy
7,309
+88
+1% +$62.6K 0.75% 18
2023
Q4
$4.21M Buy
7,221
+285
+4% +$166K 0.59% 25
2023
Q3
$3.73M Sell
6,936
-92
-1% -$47.4K 0.59% 26
2023
Q2
$3.3M Buy
7,028
+459
+7% +$192K 0.49% 33
2023
Q1
$2.26M Buy
6,569
+450
+7% +$152K 0.37% 51
2022
Q4
$2.24M Buy
6,119
+263
+4% +$93.2K 0.4% 45
2022
Q3
$1.89M Buy
5,856
+22
+0.4% +$6.97K 0.37% 50
2022
Q2
$1.89M Buy
5,834
+3,410
+141% +$1.02M 0.36% 57
2022
Q1
$695K Buy
2,424
+112
+5% +$28.8K 0.14% 156
2021
Q4
$638K Sell
2,312
-963
-29% -$244K 0.13% 180
2021
Q3
$756K Buy
3,275
+16
+0.5% +$3.95K 0.17% 137
2021
Q2
$748K Buy
3,259
+572
+21% +$115K 0.18% 137
2021
Q1
$502K Sell
2,687
-784
-23% -$153K 0.14% 178
2020
Q4
$586K Buy
3,471
+1,016
+41% +$152K 0.17% 147
2020
Q3
$363K Buy
2,455
+96
+4% +$14.9K 0.13% 191
2020
Q2
$387K Buy
2,359
+492
+26% +$75.5K 0.15% 173
2020
Q1
$259K Buy
+1,867
New +$257K 0.14% 182

Other funds holding LLY

Wealth Alliance's LLY Position: Q1 2026 in Review

Wealth Alliance reduced its Eli Lilly (LLY) stake by 2% in Q1 2026, selling an estimated $160K and leaving 7,717 shares worth $7.1M. The position accounts for 0.7% of the portfolio, ranked #27.

Wealth Alliance first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.46M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wealth Alliance held 7,717 shares of Eli Lilly worth $7.1M as of Q1 2026.
  • Wealth Alliance sold 158 Eli Lilly shares in Q1 2026, an estimated $160K.
  • Eli Lilly made up 0.7% of Wealth Alliance's portfolio in Q1 2026, its #27 holding.
  • Wealth Alliance first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • Wealth Alliance's Eli Lilly position peaked at $8.46M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.